In patients with T2DM, GIP counteracts insulin-induced hypoglycemia – most likely through a predominant glucagonotropic effect. In contrast, during hyperglycemia, GIP increases glucose disposal through a predominant effect on insulin release (Journal of Clinical Endocrinology & Metabolism)